Rethinking the management of pedunculated melanomas: A case and discussion of an amelanotic pedunculated melanoma

Authors

  • Michael Noparstak Dermatology Residency of Orlando
  • Cuong T Le Firelands Regional Medical Center

Keywords:

Pedunculated melanoma, amelanotic melanoma, melanoma

Abstract

Nodular melanomas are a common structural class of melanomas. Pedunculated melanomas constitute a rare and often aggressive variant of nodular melanoma. Pedunculated melanomas have often been grouped with other exophytic melanomas, not suspended from a free stalk, bringing controversy regarding staging and clinical management of such tumors. Due to the unique nature of pedunculated melanomas, we believe AJCC staging alone may not accurately reflect true prognosis. We present and discuss a case of pedunculated melanoma which exemplifies the key role that pathologic and genetic evaluation play in the current management of these challenging tumors.

Author Biographies

Michael Noparstak, Dermatology Residency of Orlando

Dermatology Resident PGY3

Cuong T Le, Firelands Regional Medical Center

Transitional Year Resident, PGY1

References

Rosendahl C, Hishon M, Cameron A, Barksdale S, Weedon D, Kittler H. Nodular melanoma: five consecutive cases in a general practice with polarized and non-polarized dermatoscopy and dermatopathology. Dermatol Pract Concep. 2014; 4(2): 69-75. doi:10.5826/dpc.0402a15.

Hikawa RS, Kanehisa ES, Enokihara MM, Enokihara MY, Hirata SH. Polypoid melanoma and superficial spreading melanoma different subtypes in the same lesion. An Bras Dermatol. 2014;89(4):666-8.

Anderson JH, Retterbush PD, Lesher JL. Pedunculated Melanoma. J Drugs Dermatol. 2012;11:269-70.

Gerami PCR. Development of a Prognostic Genetic Signature to Predict the Metastatic Risk Associated with Cutaneous Melanoma. Clin Cancer Res. 2015;21:175-83.

Lawson D, Russell MC, Wilkinson J, Amaria R, Gonzalez R, Gerami P et al. Development of a genetic signature that can accurately predict metastasis in stage I and II cutaneous melanoma. Pigm Cell Melanoma Res. 2013;26:970.

Zager JS, Gastman BR, Leachman S, Gonzalez RC, Fleming MD, Ferris LK et al. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients. BMC Cancer. 2018;18(130):2-11.

Duman N, Erkin G, Gokoz O, Karahan S, Kayıkçıoğlu AU, Çelik İ. Nevus-Associated versus de novo Melanoma: Do They Have Different Characteristics and Prognoses? Dermatopathology (Basel). 2015;2(1):46-51.

Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI et al. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67:472-92.

Ward CE, Maclsaac JL, Heughan CE, Weatherhead L. Metastatic Melanoma in Sentinel Node-negative Patients: The Ottawa Experience. J Cutan Med Surg. 2018;22:14-21.

Downloads

Published

2019-02-17

How to Cite

1.
Noparstak M, Le CT. Rethinking the management of pedunculated melanomas: A case and discussion of an amelanotic pedunculated melanoma. J Pak Assoc Dermatol [Internet]. 2019Feb.17 [cited 2024Mar.29];28(4):544-8. Available from: http://jpad.com.pk/index.php/jpad/article/view/1185